Navigation Links
PowderMed Announces Needle-Less Flu Vaccine

A British-based biotech firm called PowderMed Ltd has announced that it has successfully tested a new experimental DNA vaccine for flu in 36 volunteers//. The new vaccine is unique in the way that it is not administered traditionally with needles. Rather tiny particles containing the vaccine are blasted into the patients' skin.

The vaccine uses DNA from the flu virus to stimulate immunity. "DNA vaccines have the potential to significantly limit the burden of disease. The advantage of a DNA-based approach is that the vaccines can be manufactured very rapidly and in large quantities, while yielding an efficacious immune response at low doses," said Dr. Clive Dix, chief executive officer of PowderMed.

The vaccine duplicates the gene of the influenza virus or the currently prevailing bird flu virus and encloses it into small gold particles, which are then administered to patients using an injector powered by concentrated helium gas, which helps in pushing the particles beyond the skin.

'Recent years have seen a number of new influenza vaccine approaches tested in animal model systems and in the clinic. However, this study is the first successful demonstration of immunogenicity of an influenza DNA vaccine in humans,' said Dr. Hansi Dean of the International AIDS Vaccine Initiative, who was formerly with PowerMed and was the lead researcher in the study, which tested the vaccine on the 36 volunteers.

The study is published in the journal Vaccine. PowderMed said that it would now conduct bigger tests for its vaccine.


'"/>




Page: 1

Related medicine news :

1. Ramdoss Announces Introduction of RCH-II
2. Britain Announces Third Transfusion Related Mad Cow Case
3. Tibet Announces the Dalai Lama’s Tour of South Americ
4. Indian PM Announces Of Setting Up India Study Center At Tashkent
5. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Australian Government Announces Survey To Tackle Childhood Obesity
8. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
9. Apollo Announces Research on Indian Cardiac Epidemic
10. Government Announces Steps To Promote Ayurvedic Medicine
11. Merck Announces Plans for Licensing Atripla Widely in Developing World
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... , ... April 24, 2017 , ... Come to PAINWeekEnd ... 4200 Jim Walter Blvd, for an educational and exciting 2-day program. , An ... staff hearing this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads ... not found any of them to be very practical. She wanted to write a ... make changes in their health. It prompted her in writing “ A Clear Path ...
(Date:4/24/2017)... ... , ... “Reflections of God’s Work”: an enlightening collection of life lessons leading ... of published author, Jerri Broglin, a survivor of great loss who gained insight on ... eye-opener for those searching for answers, as we are finding the answers that are ...
(Date:4/24/2017)... , ... April 24, 2017 , ... “The Saint with ... with Trin, and Omega Station” is the creation of published author, Chris Jackson. ... Metroplex where he works in the Dallas Independent School District teaching English. He is ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Life of ... University of Florida. The event will be held at 7:30 pm on May 10th ... Block and Drew Copeland of Sister Hazel, will support the UF Collegiate Recovery Community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology: